A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer

Abstract excerpt

BACKGROUND: Lung cancer is the leading cause of cancer-related death in the United States. Nearly 50% of patients with stages I and II non-small cell lung cancer (NSCLC) will die from recurrent disease despite surgical resection. No reliable clinical or molecular predictors are currently available for identifying those at high risk for developing recurrent disease. As a consequence, it is not possible to select...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ferroptosis and cancer prognosis
• Share to Lung Cancer Diagnosis and Treatment
• Share to Lung Cancer Treatments and Mutations